Literature DB >> 3697936

Prognostic significance of mean cell volume in non-Hodgkin's lymphomas.

L Hauser, A Kurec, J Goldberg, R L Dubowy, F R Davey.   

Abstract

Cell volumes of neoplastic lymphocytes collected from lymph nodes of 53 patients with non-Hodgkin's lymphoma were compared to lymphocytes from 18 patients with reactive hyperplasia. The mean cell volume (MCV) and the modal volume (MV) of neoplastic lymphocytes were larger than the MCV and MV of lymphocytes from reactive hyperplasia. The cell volumes of neoplastic lymphocytes from patients with non-Hodgkin's lymphoma were more heterogeneous within and among cases than observed in volumes from lymphocytes of patients with reactive hyperplasia. The cell volumes of neoplastic lymphocytes corresponded to subgroups within the Rappaport Classification and the Working Formulation. Cell volumes of neoplastic cells from low-grade lymphomas were smaller than intermediate grade lymphomas which in turn were smaller than high-grade lymphomas. When cases of NHL were placed into three subtypes based on the MCV, large cell lymphomas had a significantly shorter survival then small and intermediate cell lymphomas at 12 months. However, a stepwise multiple regression analysis failed to demonstrate any independent value of cell volume in the prediction of survival.

Entities:  

Mesh:

Year:  1986        PMID: 3697936     DOI: 10.1002/1097-0142(19860615)57:12<2363::aid-cncr2820571221>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Application of quantifiable criteria in the Lukes and Collins classification of non-Hodgkin's lymphomas.

Authors:  H Schultz; J Ersbøll
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Cell sizing in chronic lymphoproliferative disorders: an aid to differential diagnosis.

Authors:  H D Alexander; G M Markey; R L Nolan; T C Morris
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.